Open Government Portal
Notice of Compliance with Conditions - Qualifying Notice.
Notice of Compliance with Conditions - Qualifying Notice
Notice of Compliance with Conditions - Qualifying Notice
Notice of Compliance with Conditions - Qualifying Notice
Notice of Compliance with Conditions - Qualifying Notice.
Notice of Compliance with Conditions - Qualifying Notice
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL).
The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List (PDL).
The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Ibuprofen to nonprescription status for human use by modifying the Human Prescription Drug List (PDL). The Veterinary List will remain unchanged.